NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Skin Analytics

Skin Analytics

Private
LondonHealthcare & Life Scienceshttps://skin-analytics.com/

Last Round

Series B

Apr 16, 2025

Est. Valuation

$69.97M

Total Funding Raised

$32.57M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Skin Analytics is a healthtech company that provides an artificial intelligence-powered medical device, DERM, designed for the early detection of skin cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Medical Imaging, Vertical SaaS, Computer Vision

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

clinical decision supportteledermatologyskin cancer screeningAI medical deviceAIaMDskin lesion assessmentmedical imaging AItriage softwaredigital healthdermoscopycomputer visionskin cancer detectionAI dermatologymedical SaaSNHS software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skin Analytics Comparables

Compare Skin Analytics with similar companies based on industry and business-model similarity.

Skin Analytics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MetaOptima Technology
76%
SkinIO
69%
DermaSensor, Inc.
65%

Skin Analytics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 16, 2025
GrantJul 14, 2023
GrantJul 14, 2023
GrantJun 21, 2021
Series ASep 10, 2020
Grant
Apr 1, 2019

Key People

Founding team and executive leadership

Neil Daly

Chief Executive Officer

Executive Team

Skin Analytics Investors

Notable investors and investment history

Skin Analytics investors
InvestorRounds
NHS Cancer ProgrammeGrant
SBRI HealthcareGrant
Hoxton VenturesSeries A
WayraAccelerator
NestaSeries A
Innovate UKGrant
NHS AI LabGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 87, representing 72% of headcount.

  • Jul 13, 2026

    Open roles increased to 50, representing 41% of headcount.

Skin Analytics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Skin Analytics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Skin Analytics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range121
Year Founded2012
Last FundingApr 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.